AbbVie Inc (ABBV)
170.42
-0.67
(-0.39%)
USD |
NYSE |
Nov 13, 16:00
170.65
+0.23
(+0.13%)
After-Hours: 20:00
AbbVie Gross Profit (Annual): 33.90B for Dec. 31, 2023
Gross Profit (Annual) Chart
Historical Gross Profit (Annual) Data
| Date | Value |
|---|---|
| December 31, 2023 | 33.90B |
| December 31, 2022 | 40.64B |
| December 31, 2021 | 38.75B |
| December 31, 2020 | 30.42B |
| December 31, 2019 | 25.83B |
| December 31, 2018 | 25.04B |
| December 31, 2017 | 21.17B |
| December 31, 2016 | 19.81B |
| Date | Value |
|---|---|
| December 31, 2015 | 18.36B |
| December 31, 2014 | 15.53B |
| December 31, 2013 | 14.21B |
| December 31, 2012 | 13.87B |
| December 31, 2011 | 12.80B |
| December 31, 2010 | 11.34B |
| December 31, 2009 | 10.16B |
Gross Profit Definition
Gross profit is the difference between sales and the cost of goods sold. Revenues (aka Sales) less Cost of Goods Sold (COGS) is a company's gross profit. For many companies, cost of goods sold is a substantial portion of expenses.
Gross Profit (Annual) Range, Past 5 Years
25.83B
Minimum
2019
40.64B
Maximum
2022
33.91B
Average
33.90B
Median
2023
Gross Profit (Annual) Benchmarks
| Amgen Inc | 19.74B |
| Johnson & Johnson | 58.61B |
| Eli Lilly and Co | 27.04B |
| Merck & Co Inc | 43.99B |
| Pfizer Inc | 33.54B |